Free Trial

Warby Parker (WRBY) Competitors

Warby Parker logo
$19.84 -0.33 (-1.64%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$19.75 -0.09 (-0.45%)
As of 05/23/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WRBY vs. STVN, GKOS, NARI, INSP, IRTC, BLCO, TMDX, SLNO, NVST, and PRCT

Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.

Warby Parker vs.

Stevanato Group (NYSE:STVN) and Warby Parker (NYSE:WRBY) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, community ranking, profitability, risk and earnings.

Warby Parker has a consensus price target of $22.56, suggesting a potential upside of 13.72%. Given Warby Parker's higher probable upside, analysts clearly believe Warby Parker is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.86
Warby Parker
0 Sell rating(s)
7 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.61

Stevanato Group has a net margin of 10.47% compared to Warby Parker's net margin of -4.39%. Stevanato Group's return on equity of 9.86% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group10.47% 9.86% 5.79%
Warby Parker -4.39%-8.26%-4.37%

In the previous week, Warby Parker had 29 more articles in the media than Stevanato Group. MarketBeat recorded 34 mentions for Warby Parker and 5 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.74 beat Warby Parker's score of 0.94 indicating that Stevanato Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Warby Parker
17 Very Positive mention(s)
6 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Stevanato Group has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group$1.12B5.99$157.62M$0.5143.61
Warby Parker$795.09M2.61-$63.20M-$0.12-165.33

93.2% of Warby Parker shares are owned by institutional investors. 0.7% of Stevanato Group shares are owned by insiders. Comparatively, 26.5% of Warby Parker shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Warby Parker received 23 more outperform votes than Stevanato Group when rated by MarketBeat users. However, 63.27% of users gave Stevanato Group an outperform vote while only 46.15% of users gave Warby Parker an outperform vote.

CompanyUnderperformOutperform
Stevanato GroupOutperform Votes
31
63.27%
Underperform Votes
18
36.73%
Warby ParkerOutperform Votes
54
46.15%
Underperform Votes
63
53.85%

Stevanato Group has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500. Comparatively, Warby Parker has a beta of 2.01, suggesting that its stock price is 101% more volatile than the S&P 500.

Summary

Stevanato Group beats Warby Parker on 12 of the 19 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerOphthalmic goods IndustryStaples SectorNYSE Exchange
Market Cap$2.07B$10.52B$17.59B$19.28B
Dividend YieldN/A0.96%3.07%3.85%
P/E Ratio-73.4833.9316.4234.43
Price / Sales2.613.114.3634.86
Price / CashN/A14.5316.3917.51
Price / Book6.442.576.194.69
Net Income-$63.20M$224.27M$740.28M$1.02B
7 Day Performance12.03%0.81%1.48%-2.38%
1 Month Performance25.49%11.14%4.12%4.34%
1 Year Performance14.95%-24.09%1.46%4.87%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
3.085 of 5 stars
$19.84
-1.6%
$22.56
+13.7%
+18.0%$2.07B$795.09M-73.483,030Trending News
Analyst Forecast
Analyst Revision
Gap Down
STVN
Stevanato Group
1.3307 of 5 stars
€23.64
-1.5%
N/A+10.4%$7.16B$1.10B50.304,650Positive News
GKOS
Glaukos
4.6061 of 5 stars
$94.57
+5.1%
$134.67
+42.4%
-10.5%$5.40B$404.52M-32.95780Positive News
Analyst Revision
Gap Down
NARI
Inari Medical
0.4843 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
INSP
Inspire Medical Systems
4.6612 of 5 stars
$156.54
+3.5%
$211.91
+35.4%
-7.6%$4.62B$840.11M90.49760Positive News
Gap Down
IRTC
iRhythm Technologies
1.2408 of 5 stars
$137.80
+0.1%
$128.55
-6.7%
+62.1%$4.40B$618.59M-37.861,790Positive News
Analyst Forecast
BLCO
Bausch + Lomb
4.1221 of 5 stars
$11.91
+5.6%
$15.50
+30.2%
-23.3%$4.21B$4.83B-13.0812,500Gap Up
TMDX
TransMedics Group
1.2903 of 5 stars
$118.73
+6.5%
$126.70
+6.7%
-9.7%$4.02B$488.23M126.31210Positive News
SLNO
Soleno Therapeutics
4.8386 of 5 stars
$76.70
-0.1%
$106.78
+39.2%
+86.8%$3.87BN/A-23.1030News Coverage
Positive News
Analyst Revision
NVST
Envista
4.1748 of 5 stars
$18.56
+5.5%
$20.08
+8.2%
-6.9%$3.15B$2.50B-2.8612,700Positive News
Gap Down
PRCT
PROCEPT BioRobotics
2.7834 of 5 stars
$54.44
+2.5%
$90.00
+65.3%
-14.0%$3.01B$249.12M-27.92430Positive News
Analyst Upgrade
Gap Up

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners